AU4788599A - Method for preparing 2-disubstituted 2,3-dihydrobenzofuran derivatives - Google Patents

Method for preparing 2-disubstituted 2,3-dihydrobenzofuran derivatives

Info

Publication number
AU4788599A
AU4788599A AU47885/99A AU4788599A AU4788599A AU 4788599 A AU4788599 A AU 4788599A AU 47885/99 A AU47885/99 A AU 47885/99A AU 4788599 A AU4788599 A AU 4788599A AU 4788599 A AU4788599 A AU 4788599A
Authority
AU
Australia
Prior art keywords
disubstituted
preparing
dihydrobenzofuran derivatives
dihydrobenzofuran
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU47885/99A
Inventor
Karine Couture
Veronique Gouverneur
Thierry Imbert
Patrice Mayer
Charles Mioskowski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierre Fabre Medicament SA
Original Assignee
Pierre Fabre Medicament SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre Medicament SA filed Critical Pierre Fabre Medicament SA
Publication of AU4788599A publication Critical patent/AU4788599A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C33/00—Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C33/40—Halogenated unsaturated alcohols
    • C07C33/46—Halogenated unsaturated alcohols containing only six-membered aromatic rings as cyclic parts
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/14—Unsaturated ethers
    • C07C43/178—Unsaturated ethers containing hydroxy or O-metal groups
    • C07C43/1782—Unsaturated ethers containing hydroxy or O-metal groups containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/42—Unsaturated compounds containing hydroxy or O-metal groups
    • C07C59/56—Unsaturated compounds containing hydroxy or O-metal groups containing halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/732—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids of unsaturated hydroxy carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/80—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/84—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D307/85—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU47885/99A 1998-07-13 1999-07-12 Method for preparing 2-disubstituted 2,3-dihydrobenzofuran derivatives Abandoned AU4788599A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9808981A FR2780967B1 (en) 1998-07-13 1998-07-13 PROCESS FOR THE PREPARATION OF 2,3-DIHYDROBENZOFURANE -2,2-DISUBSTITUED DERIVATIVES
FR9808981 1998-07-13
PCT/FR1999/001702 WO2000002836A1 (en) 1998-07-13 1999-07-12 Method for preparing 2-disubstituted 2,3-dihydrobenzofuran derivatives

Publications (1)

Publication Number Publication Date
AU4788599A true AU4788599A (en) 2000-02-01

Family

ID=9528598

Family Applications (1)

Application Number Title Priority Date Filing Date
AU47885/99A Abandoned AU4788599A (en) 1998-07-13 1999-07-12 Method for preparing 2-disubstituted 2,3-dihydrobenzofuran derivatives

Country Status (3)

Country Link
AU (1) AU4788599A (en)
FR (1) FR2780967B1 (en)
WO (1) WO2000002836A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0117645D0 (en) * 2001-07-19 2001-09-12 Isis Innovation Therapeutic stratergies for prevention and treatment of alzheimers disease
US7862169B2 (en) 2006-09-29 2011-01-04 Johnson & Johnson Vision Care, Inc. Contact lenses and methods for their design

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4062862A (en) * 1975-07-04 1977-12-13 Nippon Chemiphar Co., Ltd. 5-Benzyl-2-oxazolidone derivatives and a process for producing the same
FR2733983B1 (en) * 1995-05-10 1997-08-01 Pf Medicament PROCESS FOR THE PREPARATION OF AN OPTICALLY PURE BENZOFURANE CARBOXYLIC ACID DERIVATIVE AND THE USE THEREOF FOR THE PREPARATION OF EFAROXAN

Also Published As

Publication number Publication date
FR2780967B1 (en) 2000-09-29
FR2780967A1 (en) 2000-01-14
WO2000002836A1 (en) 2000-01-20

Similar Documents

Publication Publication Date Title
HUP9901769A3 (en) Data carrier, method for producing the data carrier as well as antifalsification paper
AU2709900A (en) Process for making 2,3-dihalopropanols
AU3994299A (en) Process for preparing 4-aminodiphenylamines
AU6200199A (en) Process for preparing 1,3-propanediol from methyl 3-hydroxypropionate
HUP0002105A3 (en) Method for preparing 1,1,1,3,3-pentachlorobutane
IL142285A0 (en) Process for preparing phenoxazine derivatives
AU2851899A (en) Method for producing 2,2'-dihydroxybiphenyls
HUP0102666A3 (en) Process for making 2,4-imidazolidinedione derivative
HRP20010704B1 (en) Novel morpholine derivatives, method for the produ
AU4788599A (en) Method for preparing 2-disubstituted 2,3-dihydrobenzofuran derivatives
AU7449998A (en) 2,3-dihydrobenzofuran derivatives
AU5214300A (en) Method for producing 2,2,4,4-tetra-substituted 1,3,5-cyclohexanetriones
AU1211900A (en) Method for synthesizing diaryl-substituted heterocyclic compounds, including tetrahydrofurans
AU5123300A (en) Process for preparing 10,11-methanobenzosuberane derivatives
HUP0302821A2 (en) Method for preparing substituted 5-amino-n-phenyl-1,2,4-triazole-3-sulfonamides
AU3413799A (en) Process for preparing 4-substituted cis-cyclohexylamines
HU9802105D0 (en) Process for producing 2,3,4,5-tetrafluorbenzene derivatives
ZA200005740B (en) Improved method for preparing pharmaceutically valuable norbenzomorphane derivatives.
AU2001235423A1 (en) Method for producing 2,3,5,6-tetrahalogen-xylylidene compounds
AU8437998A (en) Method for producing 4,4' dihalogendiphenylsulfone
AU6864100A (en) Method for producing 2,6-dimethylnaphthalene
AU3026697A (en) Process for preparing 4,6-diamino-resorcinol-dihydrochloride
AU5741599A (en) Method for preparing (2r)-piperidine derivatives
HUP0101063A3 (en) Process for preparing alkoxytriazolinone derivatives
AU1512800A (en) Process for preparing pyridazin-3-on derivatives

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase